Multiple is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The best peptides for this category have been ranked based on research evidence, safety profiles, and practical considerations. This guide covers the top compounds with specific dosing protocols and evidence summaries for each.
What Are the Best Peptides for Sleep?
This guide ranks the top research peptides for sleep based on current evidence, safety profiles, and practical considerations.
Each compound below has been evaluated on its mechanism of action, research depth, ease of use, and availability from quality sources.
#1: CJC-1295 — CJC-1295 (Modified GRF 1-29)
CJC-1295 is a Growth Hormone Releasing Hormone (GHRH) analog researched for increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects.
Mechanism: CJC-1295 binds to GHRH receptors on anterior pituitary somatotrophs, stimulating growth hormone synthesis and pulsatile secretion through the cAMP-PKA signaling cascade. The 'no DAC' version has a sho
Dosage: 100-300 mcg 1-3 times daily, typically before bed via subcutaneous injection. Cycle: 8-12 weeks, often paired with Ipamorelin.
Why it made the list: The 'no DAC' version is preferred over CJC-1295 DAC because it preserves natural pulsatile GH release rather than creating a sustained elevation that can desensitize receptors and suppress feedback loops. Read the full CJC-1295 guide →
#2: Ipamorelin — Ipamorelin
Ipamorelin is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.
Mechanism: Ipamorelin selectively stimulates GH release by mimicking ghrelin at the GHS-R receptor on pituitary somatotrophs. Unlike other GHRPs (GHRP-2, GHRP-6, Hexarelin), it does not significantly increase co
Dosage: 200-300 mcg 2-3 times daily via subcutaneous injection. Cycle: 8-12 weeks, often stacked with CJC-1295.
Why it made the list: The most selective GH secretagogue available — the only GHRP that doesn't meaningfully raise cortisol, prolactin, or appetite at therapeutic doses, making it the safest entry point for GH optimization. Read the full Ipamorelin guide →
#3: DSIP — Delta-Sleep-Inducing Peptide
DSIP is a Neuropeptide sleep modulator researched for improved sleep quality, increased slow-wave sleep, reduced sleep latency, stress reduction, improved sleep efficiency.
Mechanism: Promotes slow-wave (delta) sleep by stimulating acetyltransferase activity through α1 adrenergic receptors. Modulates corticotropin-releasing factor (CRF) pathways to reduce the stress response. Regul
Dosage: 100-300 mcg once daily in the evening via subcutaneous injection or intravenous. Cycle: 4-12 weeks.
Why it made the list: The only peptide isolated directly from sleep-state blood — a naturally occurring sleep molecule rather than a synthetic sedative, though clinical results have been modest compared to the compelling origin story. Read the full DSIP guide →
#4: MK-677 — Ibutamoren Mesylate
MK-677 is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue researched for oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
Mechanism: Selective non-peptide agonist of the ghrelin receptor (GHS-R1a) that increases GHRH production while simultaneously reducing somatostatin (GH inhibitor). Increases GH pulse amplitude and frequency, pr
Dosage: 10-25 mg daily once daily (usually before bed) via oral. Cycle: 8-16 weeks; minimum 10-week break between cycles.
Why it made the list: The only oral GH secretagogue producing clinically significant GH elevation without injections — uniquely accessible and practical compared to every other peptide that requires subcutaneous administration. Read the full MK-677 guide →
#5: Tirzepatide — Tirzepatide (GIP/GLP-1 dual receptor agonist)
Tirzepatide is a Dual GIP/GLP-1 receptor agonist researched for superior weight loss vs GLP-1 monotherapy, glycemic control, cardiovascular improvement, sleep apnea improvement.
Mechanism: Binds GIP receptors with native GIP affinity and GLP-1 receptors with ~5:1 weaker affinity. Dual activation amplifies insulin secretion and glucagon suppression while synergistically inhibiting appeti
Dosage: 5-15 mg weekly once weekly via subcutaneous injection. Cycle: ongoing with titration over 16 weeks.
Why it made the list: First dual GIP/GLP-1 agonist to demonstrate weight loss superiority over semaglutide in head-to-head trials — single peptide addressing both insulin physiology and appetite through two complementary incretin mechanisms. Read the full Tirzepatide guide →
Can You Combine Multiple Sleep Peptides?
Stacking complementary peptides for sleep is a common research approach. The key is combining compounds with different mechanisms to target multiple pathways without overlapping side effects.
See our stacking and cycling guide for principles on combining peptides safely.
How to Get Started
For beginners, start with a single, well-researched peptide rather than a complex stack. Use our dosing calculator for reconstitution math and our beginner's guide for step-by-step instructions.
Source from vendors with third-party COA testing — quality is the most important factor in achieving consistent research results.
Research-Grade Sourcing
If you're going to research Multiple, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Multiple?
Multiple (Multiple) is a research peptide. Synthetic peptide. It is researched for various applications.
What is the recommended Multiple dosage?
Common dosages: varies administered per protocol via subcutaneous injection. Cycle length: 4-12 weeks. Half-life: varies. Use our peptide calculator for exact reconstitution math.
What are the side effects of Multiple?
Limited safety data available. Potential injection site reactions and individual sensitivity. No serious adverse events documented in available literature.
Is Multiple safe?
Multiple has shown a preliminary safety profile in research. Not FDA-approved. Available as a research chemical in most jurisdictions. All research should follow appropriate safety protocols.